For two decades it has been assumed that inhibition of carnitine palmitoyl-
transferase I (CPT-1) by malonyl-CoA represents the main regulatory mechani
sm Of liver ketogenesis. However, recent evidence indicates that CPT-I acti
vity is also controlled by interactions between mitochondria and cytoskelet
al components. This newly recognized mechanism emphasizes the emerging role
of the cytoskeleton in the regulation of metabolic pathways.